← Leaderboards
Tracy A. Balboni
Beth Israel Deaconess Medical Center
$1,284,878
Attributed
$3,854,633
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,854,633 · 2
By mechanism
R01$3,192,651 · 1
R56$661,982 · 1
Top collaborators
- Ron N Alkalay7 shared
- David B. Hackney7 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Ron N Alkalay$3,167,761
- Mary L Bouxsein$27,309,603
- Erika M D'agata$8,559,063
- Daniel Botelho Costa$3,158,732
- Brian D Snyder$4,196,301
Others in their field
Other Emerging Leaders on “Predictive Marker”
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Susan M Landau · University Of California Berkeley$47,252,026
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$17,454,417
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$16,767,001
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$15,645,835
Research focus
Predictive MarkerSpinal FracturesMetastatic Neoplasm To The BonePathologicScanningSpinalGuidelinesMechanicsNeoplasm MetastasisPalliativeRadiationRadiation TherapyFollow-UpSensitivity And SpecificityClinically SignificantCostHigh RiskMalignant NeoplasmsFracture RiskMorbidity - Disease RateNeurologic DeficitPainClinical CareSpine Bone Structure
Grant awards (7)
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$639,383
R01 · FY2024 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$681,073
R01 · FY2023 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$676,550
R01 · FY2022 · AR
Curating musculoskeletal CT data to enable the development of AI/ML approaches for analysis of clinical CT in patients with metastatic spinal disease$352,266
R01 · FY2022 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$131,892
R01 · FY2021 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$711,487
R01 · FY2020 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$661,982
R56 · FY2019 · AR